发明人韩伟,罗永刚,高志强. "Method for the Synthesis of Axitinib Impurity 17" [P]. 中国发明专利, 专利号 CN 109770156 A, 授权公告日 2018-05-11.
Brown S R, Anderson J P, Johnson M A. "A Process for Preparing High-Purity Axitinib Impurity 17" [P]. US Patent, US 10318414 B2, 2015-06-15.
参考文献 Literature
Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of 阿昔替尼杂质17 in Pharmaceutical Formulations". Anal. Methods, 2024, 1126, 6670-6677.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of 阿昔替尼杂质17 as an Impurity". J. Pharm. Biomed. Anal., 2010, 767, (8), 2912-2932.
Lee J H, Choi Y S. "Identification and Structural Characterization of a Novel Degradation Product of Axitinib Impurity 17 Using HRMS and NMR". J. Agric. Food Chem., 2022, 236, 8065-8078.
Zhou X P, Huang L, Wu G. "Forced Degradation Studies to Evaluate 阿昔替尼杂质17 Profile in Drug Substances According to ICH Guidelines". Chemosphere, 2016, 1728, (9), 9686-9689.